InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by LaChapelle Robin. Insider active across 1 company, notably ArriVent Biopharma, Inc.. In total, 4 reports have been recorded. History available since 19 September 2024. The latest transaction was disclosed on 11 July 2025 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
LaChapelle Robin is a declarant linked to ArriVent Biopharma, Inc., where the listed function is Chief Operating Officer. The record shows 4 filings in total, and the sampled filings run from 2024-09-23 to 2025-07-15, with the transaction nature listed as option exercise.